Search the Newsreel

18 More Valvoline Service Centers Expected by End-2027

Franchise Equity Partners (FEP) portfolio company, Velocity Auto Care, has reached 50 Valvoline Instant Oil Change service centers, including a new location in Edinburg, Texas. This milestone follows FEP's partnership with Velocity in December 2024 to acquire 38 franchise locations and a seven-year development …

Valvoline Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:VVV)

Valvoline Inc. (NYSE:VVV) has published its Q3 2026 earnings call presentation. The company reported an EPS of $0.57, beating estimates by $0.07, and revenue of $544.60 million, surpassing estimates by $986.47K and showing a 24.05% year-over-year increase. This slide deck accompanies their recent earnings …

Franchise Equity Partners Marks 50-Location Milestone with Velocity Auto Care Expansion

Achievement reflects continued expansion following 2024 acquisition, with 18 additional service centers planned through 2027 NEW YORK, Aug. 5, 2026 /PRNewswire/ -- Franchise Equity Partners (FEP), a private investment firm on a mission to create long-term partnerships with quality franchisees and franchisors, today announced …

Valvoline (NYSE:VVV) Posts Earnings Results, Beats Estimates By $0.07 EPS

Alvotech (ALVO) Could Be 72% Undervalued Following FDA Inspection Closure

Alvotech (ALVO) stock is under focus after the FDA closed its May 2026 inspection with a Voluntary Action Indicated classification, leading to a recent 23.87% share price return over 7 days despite a year-to-date decline. Analysts suggest the stock is 72.2% undervalued, with a …

Valvoline Inc reports results for the quarter ended June 30 - Earnings Summary

Valvoline Inc has released its earnings summary for the quarter that ended on June 30. The full article provides detailed financial results for the company during this period.

Valvoline (NYSE:VVV) Updates FY 2026 Earnings Guidance

Valvoline (VVV) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended June 2026, Valvoline (VVV) reported revenue of $544.6 million, up 24.1% over the same period last year. EPS came in at $0.57, compared to $0.47 in the year-ago quarter. The reported revenue represents a surprise of +1.49% over the Zacks …

Is Valvoline Inc (VVV) Undervalued After Q3 Earnings Beat? EPS: $0.51, Revenue: $544.6M, GF Score: 93/100

Valvoline (VVV) Q3 Earnings and Revenues Surpass Estimates

Valvoline (VVV) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Valvoline beats Q3 estimates, raises guidance midpoints

Valvoline Inc. reported strong third-quarter results, exceeding analyst expectations for both adjusted earnings per share and revenue. The company achieved 8.0% system-wide same-store sales growth and raised its full-year fiscal 2026 revenue and same-store sales guidance, while its adjusted EPS midpoint guidance came in …

Earnings Flash (VVV) Valvoline Inc. Reports Q3 Revenue $544.6M, vs. FactSet Est of $543.2M

Valvoline Inc. reported its Q3 revenue of $544.6 million, surpassing FactSet's estimate of $543.2 million. The company, which specializes in automotive preventive maintenance services, also updated its fiscal year 2026 outlook. This financial update follows other recent news, including adjusted earnings and revenue increases …

Valvoline adds 47 net stores as system-wide sales reach $1.05B

Valvoline faces earnings test as base oil shortage reshapes market By Investing.com

Valvoline Inc. is set to report its fiscal third-quarter earnings, with analysts anticipating strong growth despite an industry-wide base oil shortage. The company is expected to leverage this supply disruption to accelerate market share gains, driven by rising wholesale motor oil prices and strategic …

Boston Partners (VVV) reports 5.17% beneficial stake in Valvoline common stock

Boston Partners has disclosed a 5.17% beneficial ownership stake in Valvoline Inc. common stock, totaling 6,597,960 shares as of June 30, 2026. The firm holds sole voting power over 6,227,151 shares and sole dispositive power over all 6,597,960 shares, primarily for discretionary client accounts. …

ALVO|Alvotech SA|Price:3.785|Chg%:-0.335

Alvotech SA (ALVO) has a relatively weak fundamental profile but high growth potential, with its valuation considered fairly valued within the Biotechnology & Medical Research industry. Institutional ownership is very high, and analysts have recently rated it as a "Buy" with a target price …

Novo misses, AstraZeneca holds steady, Alvotech clears FDA – the Nordic Pulse | 2026:31

This article provides the Nordic Life Science Weekly Report for Week 31, 2026, offering key insights into the market, major events, financial impact, development and research, and a catalyst watch. It highlights that Novo Nordisk missed expectations, AstraZeneca remained stable, and Alvotech received FDA …

Alvo Minerals Boosts Brazilian Critical Minerals Push with Touro Drilling and Government-Backed Survey

Price to earnings forward of Valvoline, Inc. – BX:0V4

This page from TradingView provides financial information for Valvoline, Inc. (BX:0V4), specifically focusing on its forward price-to-earnings ratio. The content indicates that the market is currently closed with no trades recorded.

Enterprise value to EBIT forward of Valvoline, Inc. – BX:0V4

This article displays the "Enterprise value to EBIT forward" metric for Valvoline, Inc. (BX:0V4) on the TradingView platform. It shows that the market for this stock is currently closed with no trades. The primary content is a single data point within a financial overview.

Alvotech (ALVO) Is Up 34.6% After FDA Clears Reykjavik Plant And BLAs Advance - Has The Bull Case Changed?

Alvotech (ALVO) stock rose 34.6% after the FDA cleared its Reykjavik manufacturing plant with a Voluntary Action Indicated classification, addressing previous observations and allowing the company to advance multiple Biologics License Applications (BLAs) in the US. This regulatory progress, along with the acceptance of …

Valvoline (VVV) Appoints Katherine Fogertey And Scott Mezvinsky To Its Board

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Valvoline (NYSE:VVV) has appointed Katherine Fogertey and Scott Mezvinsky to its Board of Directors. The two executives bring experience in finance, restaurant industry transformation, and …

Valvoline Inc. Releases Fiscal 2025 Impact Report Highlighting Progress in People, Communities and Environmental Stewardship

Valvoline Inc. has released its Fiscal 2025 Impact Report, detailing significant progress in areas such as employee support, community engagement, and environmental efforts. Key achievements include raising a record $1.8 million for Children’s Miracle Network, investing over $1.4 million in service center upgrades, and …

Alvotech (NASDAQ:ALVO) Given Consensus Rating of "Hold" by Brokerages

Alvotech (NASDAQ:ALVO) has received a consensus "Hold" rating from six brokerages, with an average 12-month price target of $7.60, significantly higher than its current share price of $3.53. Institutional investors like ProShare Advisors and Mirae Asset Global Investments have increased their stakes, while the …

Piper Sandler reiterates Valvoline stock rating on solid quarter outlook

Piper Sandler has reiterated an Overweight rating and a $44.00 price target for Valvoline (NYSE: VVV), predicting an 11% upside from its current trading price. The firm anticipates Valvoline will exceed estimates and raise guidance for its fiscal third quarter results, scheduled for August …

Alvotech Shares Rise After Wrapping FDA Facility Inspection

Alvotech's shares increased following the successful completion of a U.S. FDA facility inspection related to its a new biosimilar project, AVT02. The company received some observations but stated they are not expected to impact the timeline for its Humira biosimilar. This marks a significant …

VVV|Valvoline Inc|Price:39.296|Chg%:-0.354

This article provides a comprehensive stock analysis of Valvoline Inc (VVV) from TradingKey. It highlights the company's stable fundamentals, high growth potential, and fair valuation within the Personal & Household Products & Services industry. The analysis includes key insights, score breakdown, strengths like revenue …

Valvoline Inc. (VVV) Stock Forecasts

Argus has raised its target price for Valvoline Inc. (VVV) to $42.00, up from its previous target. Valvoline, a consumer cyclical company, produces and markets automotive maintenance products, primarily lubricants, to various customers. The current stock price for VVV is $39.65.

Is Valvoline’s (VVV) Board Adding Consumer Veterans Altering The Investment Case For Valvoline?

Valvoline Inc. has enhanced its Board of Directors by appointing Katherine Fogertey (former Shake Shack CFO) and Scott Mezvinsky (CEO of Yum! Brands’ KFC division), signaling a stronger focus on operational discipline, brand growth, and board oversight. While these additions bring significant consumer and …

US FDA Closes Inspection of Alvotech's Manufacturing Facility in Iceland

Alvotech has announced the successful conclusion of a U.S. FDA inspection of its manufacturing facility in Reykjavik, Iceland, with no Form 483s issued. This positive outcome is a significant step for the company, as it addresses previous issues that had prevented the approval of …

Valvoline Q3 Same-Store Sales Expected to Beat Estimates, RBC Says

RBC analysts predict Valvoline's Q3 same-store sales will surpass estimates. The article highlights recent company news, analyst ratings, and an overview of Valvoline's business, which focuses on automotive preventive maintenance services through its franchised and company-operated service centers.

Alvotech (NASDAQ:ALVO) Shares Up 13.5% - Here's What Happened

Alvotech (NASDAQ:ALVO) saw its shares climb 13.5% in mid-day trading but with significantly reduced volume. Analyst sentiment is mixed, with an average "Hold" rating and a target price of $7.60, as the company continues to report negative profitability despite $105.9 million in quarterly revenue. …

Alvotech Marks Key Milestone As FDA Closes Inspection Of Reykjavik Facility; Stock Up

(RTTNews) - Alvotech (ALVO), a biotechnology company focused on developing and manufacturing biosimilar medicines, announced that the U.S. FDA has successfully closed its inspection of the company's manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA classified the site as Voluntary Action …

FDA closes Alvotech (NASDAQ: ALVO) Iceland plant inspection with VAI status

Alvotech (NASDAQ: ALVO) announced that the U.S. FDA has closed its May 2026 inspection of its Reykjavik, Iceland manufacturing facility with a Voluntary Action Indicated (VAI) classification. The company views this as a significant milestone, reflecting enhanced quality systems and manufacturing operations. Alvotech continues …

Alvotech clears FDA inspection of Iceland manufacturing site, advancing biosimilar drug approvals.

Alvotech announced the successful closure of an FDA inspection at its manufacturing facility in Reykjavik, Iceland, which was classified as Voluntary Action Indicated (VAI). This clearance is a crucial step for Alvotech, allowing the company to advance its biosimilar drug pipeline. The company is …

Alvotech works toward FDA approval for three biosimilar applications

Alvotech announced that the FDA has closed its May 2026 inspection of the company's Reykjavik manufacturing facility with a Voluntary Action Indicated (VAI) classification, indicating concerns that the firm is asked to address voluntarily. This positive outcome reflects the company's efforts to strengthen quality …